Home
WINT
WINT News

Latest Windtree Therapeutics Inc. (WINT) News on August 23, 2025

Why Are Public Companies Amassing ETH, XRP, SOL, BNB Instead Of Just Bitcoin?

Benzinga

a month ago

Why Are Public Companies Amassing ETH, XRP, SOL, BNB Instead Of Just Bitcoin?

Kraken to Support Biotech Firm Windtree’s $200M BNB Treasury Play

CoinDesk

a month ago

Kraken to Support Biotech Firm Windtree’s $200M BNB Treasury Play

Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel

GlobeNewswire

2 months ago

Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel

Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study

GlobeNewswire

2 months ago

Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study

Windtree Receives Offer for Its Preclinical Oncology Drug Candidate

GlobeNewswire

2 months ago

Windtree Receives Offer for Its Preclinical Oncology Drug Candidate

MT Newswires

2 months ago

Windtree to Acquire Titan Environmental Services; Shares Surge

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

GlobeNewswire

2 months ago

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

Ares and Ansley Park Capital provide asset-based and equipment financing to Shimmick

Leasing Life

3 months ago

Ares and Ansley Park Capital provide asset-based and equipment financing to Shimmick

BP, EOG achieve first gas from Mento field, offshore Trinidad

Offshore Technology

3 months ago

BP, EOG achieve first gas from Mento field, offshore Trinidad

Macron urges Asia, Europe to unite to resist 'spheres of coercion'

AFP

3 months ago

Macron urges Asia, Europe to unite to resist 'spheres of coercion'

Name Game: Shoe Carnival Is Converting More Stores to Shoe Station Banner

Footwear News

3 months ago

Name Game: Shoe Carnival Is Converting More Stores to Shoe Station Banner

Business Wire

3 months ago

Form 8.3 - American Axle & Manufacturing Holdings, Inc.

Ulta Stock Jumps as Beauty Product Spending Continues

Investopedia

3 months ago

Ulta Stock Jumps as Beauty Product Spending Continues

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy

GlobeNewswire

3 months ago

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy

Anti-money Laundering (AML) Market worth $9.38 billion by 2030- Exclusive Report by MarketsandMarkets™

PR Newswire

3 months ago

Anti-money Laundering (AML) Market worth $9.38 billion by 2030- Exclusive Report by MarketsandMarkets™

Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025

GlobeNewswire

3 months ago

Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025

Windtree Therapeutics Announces Istaroxime Presentation at European Society of Cardiology Heart Failure Conference

GlobeNewswire

3 months ago

Windtree Therapeutics Announces Istaroxime Presentation at European Society of Cardiology Heart Failure Conference

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

GlobeNewswire

3 months ago

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025

GlobeNewswire

3 months ago

Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025

Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US

GlobeNewswire

4 months ago

Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US

Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development

GlobeNewswire

4 months ago

Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development

Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates

GlobeNewswire

4 months ago

Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates

Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

PR Newswire

5 months ago

Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

MT Newswires

5 months ago

Windtree Therapeutics Regains Nasdaq Compliance Over Minimum Share Price Rule

Evofem Reports Fourth Consecutive Year of Net Sales Growth

PR Newswire

5 months ago

Evofem Reports Fourth Consecutive Year of Net Sales Growth

Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules

GlobeNewswire

5 months ago

Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules

MT Newswires

5 months ago

Windtree Signs Deal to Become Sourcing Partner for Evofem's Contraceptive Vaginal Gel; Shares Rise

Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product

GlobeNewswire

5 months ago

Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product

WINT: Advancing Lead Asset; Leveraging Strategic M&A to Potentially Shorten Timeline to Revenue Generation – Initiating Coverage

Zacks Small Cap Research

6 months ago

WINT: Advancing Lead Asset; Leveraging Strategic M&A to Potentially Shorten Timeline to Revenue Generation – Initiating Coverage

Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure

GlobeNewswire

6 months ago

Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure

Windtree Files Istaroxime Cardiogenic Shock and Prevention of Arrythmias Patent for India

GlobeNewswire

6 months ago

Windtree Files Istaroxime Cardiogenic Shock and Prevention of Arrythmias Patent for India

MT Newswires

6 months ago

Windtree Therapeutics Approves 1-for-50 Reverse Stock Split; Shares Fall Pre-Bell

Windtree Therapeutics, Inc. Announces Reverse Stock Split

GlobeNewswire

6 months ago

Windtree Therapeutics, Inc. Announces Reverse Stock Split

Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference

GlobeNewswire

6 months ago

Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference

Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company’s Oncology Pipeline

GlobeNewswire

7 months ago

Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company’s Oncology Pipeline

Windtree Announces the Addition of Leanne Kelly to Its Board of Directors

GlobeNewswire

7 months ago

Windtree Announces the Addition of Leanne Kelly to Its Board of Directors

Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline

GlobeNewswire

7 months ago

Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline

Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference

GlobeNewswire

8 months ago

Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference

Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia

GlobeNewswire

8 months ago

Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia

MT Newswires

9 months ago

Sector Update: Health Care Stocks Mixed Wednesday Afternoon

MT Newswires

9 months ago

Windtree Therapeutics Engages Strategic Adviser to Evaluate Options for Cardiovascular Portfolio; Shares Fall

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction

GlobeNewswire

9 months ago

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction

Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

GlobeNewswire

9 months ago

Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

Windtree Announces Leadership Transition Plan With Industry Veterans

GlobeNewswire

9 months ago

Windtree Announces Leadership Transition Plan With Industry Veterans

WINT: Patient Enrollment in SEISMiC C Trial Starts, Patent Position Expands

Zacks Small Cap Research

9 months ago

WINT: Patient Enrollment in SEISMiC C Trial Starts, Patent Position Expands

Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong

GlobeNewswire

10 months ago

Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong

Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3

GlobeNewswire

10 months ago

Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3

Windtree Therapeutics completes national phase filings for istaroxime

TipRanks

10 months ago

Windtree Therapeutics completes national phase filings for istaroxime

Windtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World

GlobeNewswire

10 months ago

Windtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World

Windtree To Present at the ThinkEquity Conference on October 30th

GlobeNewswire

10 months ago

Windtree To Present at the ThinkEquity Conference on October 30th

Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan

GlobeNewswire

10 months ago

Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan

WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones

Zacks Small Cap Research

10 months ago

WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones

Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design

GlobeNewswire

10 months ago

Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design

Windtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic Shock

GlobeNewswire

a year ago

Windtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic Shock

Windtree Therapeutics Announces Virtual Investor Day Presentation on October 1 at 3pm ET

GlobeNewswire

a year ago

Windtree Therapeutics Announces Virtual Investor Day Presentation on October 1 at 3pm ET

Windtree Therapeutics Heart Failure Drug Candidate Improves Systolic Blood Pressure

Benzinga

a year ago

Windtree Therapeutics Heart Failure Drug Candidate Improves Systolic Blood Pressure

Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock

GlobeNewswire

a year ago

Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock

Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic Shock

GlobeNewswire

a year ago

Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic Shock

Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates

GlobeNewswire

a year ago

Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates

Windtree Announces New Additions and Changes to Its Board of Directors

GlobeNewswire

a year ago

Windtree Announces New Additions and Changes to Its Board of Directors

MT Newswires

a year ago

Top Premarket Gainers

Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data

GlobeNewswire

a year ago

Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data

Windtree Therapeutics Announces Closing of Financing Through a Private Placement of Series C Preferred Stock

GlobeNewswire

a year ago

Windtree Therapeutics Announces Closing of Financing Through a Private Placement of Series C Preferred Stock

Windtree Therapeutics Regains Compliance with Nasdaq

GlobeNewswire

a year ago

Windtree Therapeutics Regains Compliance with Nasdaq

Windtree Therapeutics Announces Reverse Stock Split

GlobeNewswire

a year ago

Windtree Therapeutics Announces Reverse Stock Split

Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

GlobeNewswire

a year ago

Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing

GlobeNewswire

a year ago

Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing

Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research

GlobeNewswire

2 years ago

Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research

Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives

GlobeNewswire

2 years ago

Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives

20 Countries With The Highest Number of Drug Trafficking in the World

Insider Monkey

2 years ago

20 Countries With The Highest Number of Drug Trafficking in the World

Splash Beverage Group Receives Notice of Plan Acceptance

NewMediaWire

2 years ago

Splash Beverage Group Receives Notice of Plan Acceptance

Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company

ACCESSWIRE

2 years ago

Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company

Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company

GlobeNewswire

2 years ago

Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company

Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

GlobeNewswire

2 years ago

Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China

ACCESSWIRE

2 years ago

Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China

Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region

GlobeNewswire

2 years ago

Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

U.S. Global Investors Announces Share Buyback Numbers for December 2023; Provides an Update on Competitive Year-End Performance for Quant Gold ETF

GlobeNewswire

2 years ago

U.S. Global Investors Announces Share Buyback Numbers for December 2023; Provides an Update on Competitive Year-End Performance for Quant Gold ETF

7 Tech Stocks Destined to Follow in Nvidia’s Footsteps

InvestorPlace

2 years ago

7 Tech Stocks Destined to Follow in Nvidia’s Footsteps

Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress

GlobeNewswire

2 years ago

Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress

Wearable Devices to Present its Mudra Band at the 2024 CES

GlobeNewswire

2 years ago

Wearable Devices to Present its Mudra Band at the 2024 CES

Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator

GlobeNewswire

2 years ago

Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator

GlobeNewswire

2 years ago

Asia Pacific Wire & Cable Corporation Limited Reports Third Quarter 2023 Financial Results

GREENBROOK TMS RAISES US$5.3 MILLION IN DEBT FINANCING

CNW Group

2 years ago

GREENBROOK TMS RAISES US$5.3 MILLION IN DEBT FINANCING

Be Wary Of Asia Pacific Wire & Cable (NASDAQ:APWC) And Its Returns On Capital

Simply Wall St.

2 years ago

Be Wary Of Asia Pacific Wire & Cable (NASDAQ:APWC) And Its Returns On Capital

KULR Announces Closing of $1.035 Million All-Common Stock Public Offering, Including Full Exercise of Over-Allotment Option

GlobeNewswire

2 years ago

KULR Announces Closing of $1.035 Million All-Common Stock Public Offering, Including Full Exercise of Over-Allotment Option

Royalty Management Holding Corporation's Portfolio Company, Ferrox Holdings Ltd, Commences Production from its Tivani Project

ACCESSWIRE

2 years ago

Royalty Management Holding Corporation's Portfolio Company, Ferrox Holdings Ltd, Commences Production from its Tivani Project

Calculating The Fair Value Of U.S. Energy Corp. (NASDAQ:USEG)

Simply Wall St.

2 years ago

Calculating The Fair Value Of U.S. Energy Corp. (NASDAQ:USEG)

Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024

ACCESSWIRE

2 years ago

Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024

Evaxion Biotech Announces Private Placement Financing

GlobeNewswire

2 years ago

Evaxion Biotech Announces Private Placement Financing

Biora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery Platform

GlobeNewswire

2 years ago

Biora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery Platform

One Hennessy Advisors Insider Raised Their Stake In The Previous Year

Simply Wall St.

2 years ago

One Hennessy Advisors Insider Raised Their Stake In The Previous Year

We Think VirnetX Holding (NYSE:VHC) Needs To Drive Business Growth Carefully

Simply Wall St.

2 years ago

We Think VirnetX Holding (NYSE:VHC) Needs To Drive Business Growth Carefully

PR Newswire

2 years ago

MIND TECHNOLOGY, INC. REPORTS FISCAL 2024 THIRD QUARTER RESULTS

CHEERS Telepathy Elevates to AI Marketing Tool for Creative Content Across the Value Chain

PR Newswire

2 years ago

CHEERS Telepathy Elevates to AI Marketing Tool for Creative Content Across the Value Chain

Envirotech Vehicles Announces Pilot Program with Crossno Corp., a Regional FedEx Ground Contractor

ACCESSWIRE

2 years ago

Envirotech Vehicles Announces Pilot Program with Crossno Corp., a Regional FedEx Ground Contractor

PR Newswire

2 years ago

The9 Limited Raised US$12 million in a Private Placement Transaction to Fund Business Growth

PR Newswire

2 years ago

MIND TECHNOLOGY ANNOUNCES FISCAL 2024 THIRD QUARTER EARNINGS RELEASE AND CONFERENCE CALL SCHEDULE

MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters

GlobeNewswire

2 years ago

MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters

Companies Like Sangamo Therapeutics (NASDAQ:SGMO) Could Be Quite Risky

Simply Wall St.

2 years ago

Companies Like Sangamo Therapeutics (NASDAQ:SGMO) Could Be Quite Risky

Share on Social Networks: